Wide QRS Complex and Lateral ST-T Segment Abnormality are Associated with Worse Clinical Outcomes in COVID-19 Patients

Sonsoz, Mehmet Rasih; Oncul, Aytac; Cevik, Erdem; Orta, Huseyin; Yilmaz, Mustafa; Govdeli, Elif Ayduk; Nalbant, Asli; Demirtakan, Zeynep Gizem; Tonyali, Mirac; Durmus, Damla; Anakli, Ilkay; Polat, Ozlem; Catma, Yunus; Senkal, Naci; Medetalibeyoglu, Alpay; Kose, Murat; Emet, Samim; Tukek, Tufan

BACKGROUND: The information on electrocardiographic features of patients with coronavirus disease 2019 (COVID-19) is limited. Our aim was to determine if baseline electrocardiographic features of hospitalized COVID-19 patients are associated with markers of myocardial injury and clinical outcomes. METHODS: In this retrospective, single center cohort study, we included 223 hospitalized patients with laboratory-confirmed COVID-19. Clinical, electrocardiographic and laboratory data were collected and analyzed. Primary composite endpoint of mortality, need for invasive mechanical ventilation, or admission to the intensive care unit was assessed. RESULTS: Forty patients (17.9%) reached the primary composite endpoint. Patients with the primary composite endpoint were more likely to have wide QRS complex (>120 ms) and lateral ST-T segment abnormality. The multivariable Cox regression showed increasing odds of the primary composite endpoint associated with acute respiratory distress syndrome (odds ratio 7.76, 95% CI 2.67 – 22.59; P <0.001), acute cardiac injury (odds ratio 3.14, 95% CI 1.26 – 7.99; P = 0.016), high flow oxygen therapy (odds ratio 2.43, 95% CI 1.05 – 5.62; P = 0.037) and QRS duration longer than >120 ms (odds ratio 3.62, 95% CI 1.39 – 9.380; P = 0.008) Patients with a wide QRS complex (>120 ms) had significantly higher median level of troponin T and pro-BNP than those without it. Patients with abnormality of lateral ST-T segment had significantly higher median level of troponin T and pro-BNP than patients without. CONCLUSIONS: The presence of QRS duration longer than 120 ms and lateral ST-T segment abnormality were associated with worse clinical outcomes and higher levels of myocardial injury biomarkers.